Biblio
Autologous bone marrow mononuclear cells to treat severe traumatic brain injury in children. Brain. 2024.
Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI. PLoS One. 2021;16(12):e0261599.
. A decade of blood-brain barrier permeability assays: Revisiting old traumatic brain injury rat data for new insights and experimental design. Microvasc Res. 2022;145:104453.
. Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury. Stem Cells Transl Med. 2020:e12706.
. Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model. PLoS One. 2021;16(5):e0251601.
. Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products. Stem Cells Transl Med. 2022;11(1):2-13.
. . .